Q2 2013 Holdings
Filed 2013-08-14 | 114 holdings | $142.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Angiodynamics Inc(ANGO) | COM | 03475V101 | $29.9M | 2,651,466 | 21.0% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $25.5M | 617,000 | 17.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $21.5M | 694,000 | 15.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $19.4M | 1,067,115 | 13.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $13.8M | 247,000 | 9.7% |
| Cross Ctry Healthcare Inc(CCRN) | COM | 227483104 | $8.2M | 1,582,227 | 5.7% |
| Accuray Inc(ARAY) | COM | 004397105 | $8.2M | 1,420,000 | 5.7% |
| Allscripts Healthcare Solutn(MDRX) | COM | 01988P108 | $8.0M | 619,360 | 5.6% |
| Atricure Inc(ATRC) | COM | 04963C209 | $6.0M | 630,000 | 4.2% |
| Dendreon Corp | NOTE 2.875% 1/1 | 24823QAC1 | $84.4K | $114,140,000 | 0.1% |
| Auxilium Pharmaceuticals Inc | COM | 05334D107 | $80.7K | 4,850,644 | 0.1% |
| Cubist Pharmaceuticals IncCall | COM | 229678107 | $72.4K | 1,500,000 | 0.1% |
| Exelixis Inc | NOTE 4.250% 8/1 | 30161QAC8 | $65.4K | $67,000,000 | 0.0% |
| Nuvasive Inc | NOTE 2.750% 7/0 | 670704AC9 | $61.1K | $61,136,000 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $55.8K | 3,909,914 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $52.0K | 1,855,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $49.4K | 10,885,406 | 0.0% |
| Teva Pharmaceutical Inds LTD(TEVA) | ADR | 881624209 | $48.7K | 1,242,759 | 0.0% |
| Hologic Inc | DEBT 2.000% 3/0 | 436440AC5 | $47.6K | $47,516,000 | 0.0% |
| Volcano Corporation | NOTE 1.750%12/0 | 928645AB6 | $46.1K | $50,000,000 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $43.9K | 928,000 | 0.0% |
| Keryx Biopharmaceuticals Inc | COM | 492515101 | $43.8K | 5,864,612 | 0.0% |
| Optimer Pharmaceuticals Inc | COM | 68401H104 | $43.8K | 3,025,829 | 0.0% |
| Sagent Pharmaceuticals Inc | COM | 786692103 | $43.7K | 2,082,167 | 0.0% |
| Integra Lifesciences Hldgs C | NOTE 1.625%12/1 | 457985AK5 | $40.6K | $41,523,000 | 0.0% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $39.1K | 9,400,000 | 0.0% |
| Forest Labs Inc | COM | 345838106 | $38.7K | 945,000 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $38.1K | 2,354,963 | 0.0% |
| Intermune Inc | NOTE 2.500% 9/1 | 45884XAE3 | $34.1K | $41,570,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $34.0K | 2,939,741 | 0.0% |
| Cubist Pharmaceuticals Inc | COM | 229678107 | $33.6K | 695,000 | 0.0% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $33.0K | 700,000 | 0.0% |
| Allergan Inc | COM | 018490102 | $31.6K | 375,300 | 0.0% |
| Community Health SYS Inc New(CYH) | COM | 203668108 | $29.8K | 636,124 | 0.0% |
| Brookdale SR Living Inc | NOTE 2.750% 6/1 | 112463AA2 | $29.5K | $25,000,000 | 0.0% |
| AIR Methods Corp | COM PAR $.06 | 009128307 | $29.4K | 869,025 | 0.0% |
| Tornier N V | SHS | N87237108 | $28.8K | 1,646,318 | 0.0% |
| Universal Amern Corp New | COM | 91338E101 | $27.2K | 3,065,003 | 0.0% |
| Catamaran CorpCall | COM | 148887102 | $26.8K | 550,000 | 0.0% |
| Merck & Co Inc New(MRK) | COM | 58933Y105 | $26.7K | 575,000 | 0.0% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $26.6K | 4,333,475 | 0.0% |
| Allergan IncCall | COM | 018490102 | $25.3K | 300,000 | 0.0% |
| ST Jude MED Inc | COM | 790849103 | $24.0K | 525,000 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $22.2K | 350,000 | 0.0% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $22.1K | 1,265,104 | 0.0% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $21.8K | $23,000,000 | 0.0% |
| Heartware Intl Inc | COM | 422368100 | $21.4K | 225,167 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $21.2K | 570,000 | 0.0% |
| Cytokinetics Inc | COM | 23282W100 | $20.6K | 1,779,622 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $20.5K | 306,018 | 0.0% |